Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)
South Korea · Delayed Price · Currency is KRW 3,075.00
+80.00 (2.67%)
At close: May 21, 2026
Kookjeon Pharmaceutical Revenue
In the year 2025, Kookjeon Pharmaceutical had annual revenue of 131.04B KRW, down -3.98%. Kookjeon Pharmaceutical had revenue of 30.21B in the quarter ending December 31, 2025, a decrease of -6.00%.
Revenue
131.04B
Revenue Growth
-3.98%
P/S Ratio
1.27
Revenue / Employee
736.18M
Employees
178
Market Cap
166.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 131.04B | -5.43B | -3.98% |
| Dec 31, 2024 | 136.47B | 14.47B | 11.86% |
| Dec 31, 2023 | 122.00B | 18.29B | 17.63% |
| Dec 31, 2022 | 103.71B | 18.36B | 21.51% |
| Dec 31, 2021 | 85.35B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Powernet Technologies | 447.04B |
| Intelligent Digital Integrated Security | 327.60B |
| Daihan Pharmaceutical | 208.61B |
| Genic | 78.20B |
| Knowmerce | 75.73B |
| High Tech Pharm | 70.18B |
| HB SOLUTION | 62.85B |
| Vivozon Pharmaceutical | 59.34B |